tribiotica.com
TriBiotica - Novel Targeted Therapies for Cancer
http://www.tribiotica.com/Tbta-People.htm
Gary is also the co-founder of TripleSharp Venture Engineering, and former CEO and co-founder of Thrive Bioscience, Inc. In addition, he was co-founder and former CEO of Sage Science, Inc. Chairman of the Board. Jim is a renowned immunologist, with a special focus on tumor immunology. He pioneered the study of tumor-infiltrating lymphocytes, and the phenomenon of tumor antigen-silencing. He has been a staff member of the Pathology Department of Harvard University at the Massachusetts General Hospital for...
lauderpartners.com
Lauder Partners Investments
http://www.lauderpartners.com/investments/index.html
Current and past investments of Lauder Partners / Gary Lauder that turned out OK or are too soon to tell. (The ones that did not turn out ok are the expensive tuition we VC's pay.). Current portfolio companies (still private):. Sorted by date of investment. Most recent first. Last updated 2/13. Fka) stands for "Formerly Known As". Hyperloop One (12/15) (Shooting people (and their stuff) through tubes.) ( https:/ hyperloop-one.com/. Trusted Insight (4/10)(Institutional Investor marketplace for alternative...
nsiv.org
Biotech Companies « nsiv.org
http://nsiv.org/portfolio-2/biotech-companies-3
Officers/Management & Board of Directors. Grants & Support. Metrics of NSIV’s Success. IVIVA Medical, Inc. Adecto Pharmaceuticals identified a critical driver of tumor growth and metastasis and is developing antibody-based therapeutics against triple-negative breast cancer and other aggressive malignancies. Gail Sonenshein, President; Nora Mineva, CSO. Vladislav Bergo, CEO. Ashok Chander,CEO; Mani Foroohar,CSO. Cell Assay Innovations, Inc. Deborah Moshinsky, President; LiPing Wu, CSO. Developing a novel ...
lifesciencenation.com
Investor Platform Clients - Life Science Nation
http://www.lifesciencenation.com/investor-platform-clients
Branding & Messaging. News & White Papers. Run a Sample Search. Run a Sample Search. The LSN Investor platform is the most intuitive system for sourcing investors for a company seeking funding in the life science arena. Request a full demonstration with a member of our business development team. Hot Investor Mandate 1: Australia-Based Firm Invests in Clinical-Stage Drugs and Marketed Devices. Hot Investor Mandate 2: Pharma Seeks Therapeutics in Cardiology, Metabolism, Oncology, and CNS.
cummingsproperties.com
Media Release Archives
http://www.cummingsproperties.com/press_releases.htm
NeuroMetrix opens new clean manufacturing facility in Woburn. WOBURN, January 9, 2015 - NeuroMetrix. Began 2015 with a new 6,000-square-foot production facility at Cummings Properties' 4-B Gill Street location. The opening of the Woburn site coincides with NeuroMetrix's launch of its latest pain-management device, called Quell. (. MassPay to double its space at Cummings Center. Jason Maxwell, founder and president of MassPay, shared the news of the move in a communication to employees last month. (.